UBS Group
EVAR

UBS Group’s Lombard Medical, Inc. EVAR Stock Holding History

UBS Group’s Portfolio EVAR Stock Details EVAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,276
Closed -$2K – 8398
2017
Q3 		$2K Sell
5,276
-1,815
-26% -$888 ﹤0.01% 7535
2017
Q2 		$4K Sell
7,091
-813
-10% -$423 ﹤0.01% 7256
2017
Q1 		$6K Sell
7,904
-16,659
-68% -$10.9K ﹤0.01% 6954
2016
Q4 		$15K Buy
24,563
+19,551
+390% +$15.2K ﹤0.01% 6710
2016
Q3 		$5K Buy
5,012
+5,011
+501,100% +$5.32K ﹤0.01% 7163
2016
Q2 		$0 Hold
1
– – ﹤0.01% 8193
2016
Q1 		$0 Buy
+1
New +$1 ﹤0.01% 8575
2015
Q4 		– Sell
-4,001
Closed -$14K – 8755
2015
Q3 		$14K Buy
4,001
+3,727
+1,360% +$14.3K ﹤0.01% 7045
2015
Q2 		$1K Buy
274
+183
+201% +$838 ﹤0.01% 8376
2015
Q1 		$0 Sell
91
-24
-21% -$123 ﹤0.01% 9791
2014
Q4 		$1K Buy
+115
New +$755 ﹤0.01% 9596

Other funds holding EVAR

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

UBS Group's EVAR Position: Q4 2017 in Review

UBS Group sold out of Lombard Medical, Inc. (EVAR) in Q4 2017, closing a stake of 5,276 shares — an estimated $2K sold.

UBS Group first reported a position in EVAR in Q4 2014 and held it in 11 quarters. The position peaked at $15K in Q4 2016. 2 funds tracked by Wall St. Rank hold EVAR as of Q4 2017.

  • UBS Group reported no remaining Lombard Medical, Inc. position as of Q4 2017 after selling out during the quarter.
  • UBS Group sold 5,276 Lombard Medical, Inc. shares in Q4 2017, an estimated $2K.
  • UBS Group first reported a position in Lombard Medical, Inc. in Q4 2014 and held it in 11 quarters.
  • UBS Group's Lombard Medical, Inc. position peaked at $15K in Q4 2016.
  • 2 funds tracked by Wall St. Rank held Lombard Medical, Inc. as of Q4 2017.

Based on UBS Group's 13F filing for Q4 2017, filed 14 Feb 2018.